X4 Pharmaceuticals's total assets for Q2 2025 were $105.17M, a decrease of -19.11% from the previous quarter. XFOR total liabilities were $101.20M for the fiscal quarter, a -5.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.